Oncomatryx Conjugados Anticuerpo Fármaco contra el estroma tumoral: El principio del fin? por Mirella Zulueta, Business Development Director en Oncomatryx The potential of a technology trigger Despite many research breakthroughs over the last few decades, conventional cancer treatment strategies still face many limitations. Antibody-drug conjugates (ADCs) belong to a fairly new class of targeted … Leer más
Oncomatryx asistirá a BIOEUROPE. November 7-9. Colonia. Alemania FOCUS. November 9-12. Chipre. Si va asistir a alguno de estos eventos y desea concertar una reunión con nosotros rellene por favor el siguiente formulario. [contact-form-7 id=»2869″ title=»Conference Appointment»]
Oncomatryx will attend BIOEUROPE. November 7-9. Cologne. FOCUS. November 9-12. Cyprus. If you are also attending any of these events and you would like to meet us please fill this form to arrange an appointment. [contact-form-7 id=»2869″ title=»Conference Appointment»]
Oncomatryx en «Cancer Metabolism and the Tumour Microenvironment Conference». 9-12, Noviembre. Paphos, Chipre. Dra. Myriam Fabre (Oncomatryx R&D Director) asistirá a la conferencia como ponente: TARGETING TUMOR MICROENVIRONMENT TO TREAT INVASIVE TUMORS: OMTX705, A POWERFUL FAP-SPECIFIC ANTIBODY-DRUG CONJUGATE. Más información Si va a asistir a la conferencia y quiere acordar una reunión rellene el formulario adjunto. [contact-form-7 … Leer más
Oncomatryx at the «Cancer Metabolism and the Tumour Microenvironment Conference». 9-12, November. Paphos, Cyprus. Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker: TARGETING TUMOR MICROENVIRONMENT TO TREAT INVASIVE TUMORS: OMTX705, A POWERFUL FAP-SPECIFIC ANTIBODY-DRUG CONJUGATE. More info If you are also attending the conference and would like to meet us please fill … Leer más
[vc_row][vc_column][vc_column_text] [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column width=»1/2″][vc_column_text] Oncomatryx en la BIO 2016.del 6 al 9 de Junio. San Francisco. Si va a asistir a la convención y desea acordar una reunión, puede rellenar el formulario adjunto.[/vc_column_text][/vc_column][vc_column width=»1/2″][contact-form-7 id=»804″ title=»BIO appointment»][/vc_column][/vc_row]
[vc_row][vc_column][vc_column_text] [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column width=»1/2″][vc_column_text] Oncomatryx at BIO 2016. June 6-9. San Francisco. If you are also attending Bio convention and would like to meet us please fill this form to arrange an appointment. [/vc_column_text][/vc_column][vc_column width=»1/2″][contact-form-7 id=»804″ title=»BIO appointment»][/vc_column][/vc_row]
Presentación en el 2º Congreso Internacional ASPIC. 28-29 Abril, 2016. Oporto. Portugal. Nos complace comunicar que el equipo de Enrique De Álava del Hospital Virgen del Rocío de Sevilla presentará en el ASPIC el poster “Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies” que cuenta con los resultados obtenidos con el trabajo de investigación desarrollado … Leer más
Poster presentation at the 2nd ASPIC International Congress. 28-29 April, 2016. Porto. Portugal. We are pleased to inform you that Enrique De Alava team from Hospital Virgen del Rocío, Sevilla, Spain, will present the poster Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies” at the ASPIC, with the results obtained from research work … Leer más
[vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column width=»1/2″][vc_column_text] BIO-EUROPE Spring 2016. April 4-6, 2016. Stockholm, Sweden. Oral Presentation: “Tumor microenvironment – targeted biopharmaceuticals”. Laureano Simón, PhD Si vas a asistir a la Bio-Europe y quieres que nos veamos, por favor rellena este formulario.[/vc_column_text][/vc_column][vc_column width=»1/2″][contact-form-7 id=»804″ title=»Meeting at BIO SPRING»][/vc_column][/vc_row]
